نتائج البحث - R. Tarnawski

  • يعرض 1 - 10 نتائج من 10
تنقيح النتائج
  1. 1
    Global challenges of radiotherapy for the treatment of locally advanced cervical cancer

    Global challenges of radiotherapy for the treatment of locally advanced cervical cancer حسب Jyoti Mayadev, Guihao Ke, Umesh Mahantshetty, M.D. Pereira, R. Tarnawski, Takafumi Toita

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    The Prognostic Value of the Systemic Immune-Inflammation Index (SII) and Red Cell Distribution Width (RDW) in Patients with Cervical Cancer Treated Using Radiotherapy

    The Prognostic Value of the Systemic Immune-Inflammation Index (SII) and Red Cell Distribution Width (RDW) in Patients with Cervical Cancer Treated Using Radiotherapy حسب Emilia Staniewska, Karolina Grudzień, Magdalena Stankiewicz, Katarzyna Raczek-Zwierzycka, Justyna Rembak-Szynkiewicz, Zuzanna Nowicka, R. Tarnawski, Marcin Miszczyk

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    DALSA: Domain Adaptation for Supervised Learning From Sparsely Annotated MR Images

    DALSA: Domain Adaptation for Supervised Learning From Sparsely Annotated MR Images حسب Michael Goetz, Christian Weber, F. Bińczyk, Joanna Polańska, R. Tarnawski, Barbara Bobek‐Billewicz, Ullrich Koethe, Jens Kleesiek, Bram Stieltjes, Klaus Maier‐Hein

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study

    Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, contr... حسب Burt Nabors, Karen Fink, Tom Mikkelsen, Danica Grujičić, R. Tarnawski, Do Hyun Nam, Maria Mazurkiewicz‐Bełdzińska, Michael Salacz, Lynn S. Ashby, Vittorina Zagonel, Roberta Depenni, James Perry, Christine Hicking, Martin Picard, Monika E. Hegi, Benoît Lhermitte, David A. Reardon

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer

    Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer حسب Marcin Kubeczko, Dorota Gabryś, Marzena Gawkowska‐Suwińska, Anna Polakiewicz-Gilowska, Alexander Jorge Cortez, Aleksandra Krzywon, Grzegorz Woźniak, Tomasz Latusek, Aleksandra Leśniak, K Swiderska, Marta Mianowska-Malec, Barbara Łanoszka, Konstanty Chomik, Mateusz Gajek, Anna Michalik, Elżbieta Nowicka, R. Tarnawski, Tomasz Rutkowski, Michał Jarząb

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    191MO KEYNOTE-355: Outcomes in patients who discontinued chemotherapy before pembrolizumab and in patients with immune-mediated AEs

    191MO KEYNOTE-355: Outcomes in patients who discontinued chemotherapy before pembrolizumab and in patients with immune-mediated AEs حسب Hope S. Rugo, David W. Cescon, S-A. Im, Mastura Md Yusof, Cristián Araneda, O. N. Lipatov, F. Cruz, Carlos H. Barrios, Roberto Hegg, Élise Martin, M.A. Torregroza Otero, Nicholas C. Turner, Péter Árkosy, R. Tarnawski, Vassiliki Karantza, W. Pan, Z. Guo, Javier Cortés

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001

    Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001 حسب Christian Marth, R. Tarnawski, Alexandra Tyulyandina, Sandro Pignata, Lucy Gilbert, Diego Kaen, María Jesús Rubio, Sophia Frentzas, Mario Beiner, Manuel Magallanes-Maciel, Laura Farrelly, Chel Hun Choi, Regina Berger, Christine Lee, Christof Vulsteke, Kosei Hasegawa, Elena Ioana Braicu, Xiaohua Wu, Jodi A. McKenzie, John J. Lee, Vicky Makker

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    O001/#504 Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trial

    O001/#504 Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, pl... حسب Bradley J. Monk, Takafumi Toita, Xiaohua Wu, Juan Carlos Vázquez Limón, Qi Zhou, R. Tarnawski, Masaki Mandai, Ronnie Shapira‐Frommer, Umesh Mahantshetty, Maria Del Pilar Estevez-Diz, Francisco Ramirez Godinez, Szilvia Varga, M.H. Leiva Gálvez, Jung‐Yun Lee, Yulia Kreynina, Kathryn Howells, Sophie Wildsmith, Hannah Dry, Ana Tablante Nunes, Jyoti Mayadev

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)

    Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTEC... حسب Loren K. Mell, Igor Sirák, Lichun Wei, R. Tarnawski, Umesh Mahantshetty, Catheryn M. Yashar, Michael McHale, Ronghui Xu, Gordon Honerkamp‐Smith, Ruben Carmona, Mary E. Wright, Casey W. Williamson, Linda Kašaová, Nan Li, Stephen F. Kry, Jeff M. Michalski, Walter Bosch, William L. Straube, Julie K. Schwarz, Jessica Lowenstein, Steve Jiang, Cheryl Saenz, Steve Plaxe, John P. Einck, Chonlakiet Khorprasert, Paul P. Koonings, Terry A. Harrison, Mei Shi, Arno J. Mundt

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

    Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomis... حسب Roger Stupp, Monika E. Hegi, Thierry Gorlia, Sara Erridge, James Perry, Yong-Kil Hong, Kenneth Aldape, Benoît Lhermitte, Torsten Pietsch, Danica Grujičić, Joachim P. Steinbach, Wolfgang Wick, R. Tarnawski, Do‐Hyun Nam, Peter Hau, Astrid Weyerbrock, Martin Klein, Chiung‐Chyi Shen, Nalini Rao, László Thurzó, Ulrich Herrlinger, Tejpal Gupta, Rolf‐Dieter Kortmann, Krystyna Adamska, Catherine McBain, Alba A. Brandes, J. C. Tonn, Oliver Schnell, Thomas Wiegel, Chae‐Yong Kim, Burt Nabors, David A. Reardon, Martin J. van den Bent, Christine Hicking, Andriy Markivskyy, Martin Picard, Michael Weller

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: